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ABSTRACT

Racial and ethnic disparities in chronic obstructive pulmonary disease (COPD) are not well-studied.
Our objective was to examine differences in limited COPD-related outcomes between three minority
groups—African Americans (AAs), Hispanics, and American Indians (AIs) versus non-Hispanic Whites
(NHWs), as the referent group, in separate cohorts. Separate cross-sectional evaluations were performed
of three US-based cohorts of subjects at risk for COPD: COPDGene Study with 6,884 NHW and 3,416
AA smokers; Lovelace Smokers’ Cohort with 1,598 NHW and 378 Hispanic smokers; and Mining Dust
Exposure in the United States Cohort with 2,115 NHW, 2,682 Hispanic, and 2,467 AI miners.
Prebronchodilator spirometry tests were performed at baseline visits using standard criteria. The
primary outcome was the prevalence of airflow obstruction. Secondary outcomes were self-reported
physician diagnosis of COPD, chronic bronchitis, and modified Medical Research Council dyspnea
score. All minority groups had a lower prevalence of airflow obstruction than NHWs (adjusted ORs
varied from 0.29 in AIs to 0.85 in AAs; p < 0.01 for all analyses). AAs had a lower prevalence of chronic
bronchitis than NHWs. In our study, all minority groups had a lower prevalence of airflow obstruction
but a greater level of self-reported dyspnea than NHWs, and covariates did not explain this association.
A better understanding of racial and ethnic differences in smoking-related and occupational airflow
obstruction may improve prevention and therapeutic strategies.
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Introduction
Chronic obstructive pulmonary disease (COPD) is the third
leading cause of death in the United States [1]. More than
11 million people in the United States have been diagnosed
with COPD, but millions more may have the disease without
even knowing it [1]. The two major phenotypes of COPD
are chronic bronchitis and emphysema. Often, chronic bronchitis and emphysema phenotypes are concomitantly present.
Although cigarette smoking is the most important risk factor
for COPD in the United States, it is estimated that the
occupational contribution to the population burden of

COPD is about 15% [2]. Some workers are at particularly
high risk for developing COPD, such as those who work in
dusty trades, including miners, but COPD in these workers
is inadequately studied. In recent years, COPD prevalence
has increased among racial and ethnic minorities [3].
COPD-related outcomes may differ by race and ethnicity,
but disparities in these outcomes between minority and
non-minority groups across the United States are not
well-studied. These disparities constitute a critical gap in
knowledge since current minorities in the United States are
expected to become the majority in approximately 2044 [4].
Our objective was to examine differences in limited
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COPD-related outcomes between non-Hispanic Whites
(NHWs, referent group) versus three racial and ethnic
minority groups (African Americans (AAs), Hispanics, and
American Indians (AIs)), by separately analyzing three
at-risk cohorts, including smokers and/or miners without
pooling of data across cohorts. Based upon our previous
studies [5, 6], we hypothesized that minority groups have
a lower prevalence of COPD-related outcomes than NHWs.

Materials and methods
Study design
Separate cross-sectional analyses of data were performed
from baseline evaluations from three longitudinal US-based
studies with significant proportions of minority smokers or
miners, subjects at risk for developing COPD. NHW participants in each cohort study served as the referent group
for separate comparison with minority participants in that
cohort without pooling data across cohorts.
Study population
The COPDGene Study (www.copdgene.org) recruited 6,884
NHW and 3,416 AA smokers with ≥10 pack-years exposure, age 45–80 years, from 21 clinical centers across the
United States between 2008 and 2011. Full inclusion and
exclusion criteria and study design have been described
previously [7].
The Lovelace Smokers’ Cohort (LSC) recruited 1,598
NHW and 378 Hispanic smokers, mostly women, from
Albuquerque, and surrounding New Mexico communities,
aged 40–75 years, with ≥10 pack-years of smoking since
March 2001. Full inclusion and exclusion criteria and study
design have been described previously [5, 6].
The Mining Dust Exposure in the United States (MiDUS)
Cohort recruited 2,115 NHW, 2,682 Hispanic, and 2,467 AI
miners, mostly men, without regard to smoking history.
Subjects were recruited from mobile screening clinics held
at 20 largely rural communities in New Mexico by rotation
from 1989 to 2016. Full inclusion and exclusion criteria and
study design have been described previously [8, 9].
Measurements
Demographic information, including age, smoking history,
environmental exposure history, and history of respiratory
disease, was obtained using the adult American Thoracic
Society (ATS)-Diffuse Lung Disease (DLD)-78 questionnaire
[10]. Race and ethnicity were self-reported.
Prebronchodilator spirometry tests were performed by
trained respiratory therapists using standard criteria [11]. The
third National Health and Nutrition Examination Survey
(NHANES III) predicted values for Caucasian Americans, AA,
and Mexican Americans were used for the NHW, AA, and
Hispanic study populations, respectively [12], and Crapo reference standard for AIs [13] was used. Dyspnea was quantified
using the five-point modified Medical Research Council

(mMRC) dyspnea scale, which asks respondents to rate dyspnea
from 0 (absent) to 4 (dyspnea when dressing/undressing) [14].
Predictor and outcome
Self-reported race and ethnicity were examined as the predictor variable. The primary outcome was the baseline prevalence of airflow obstruction. The latter was defined in two
ways, as determined by the values of the ratio of forced
expiratory volume in one second (FEV1)/forced vital capacity
(FVC) of either less than 70% (absolute) or less than the
statistically-defined lower limit of normal (LLN), corresponding to a z score of −1.645 [15]. Our secondary outcomes were self-reported physician diagnosis of COPD,
chronic bronchitis, and modified Medical Research Council
(mMRC) dyspnea score at baseline evaluation [14]. Chronic
bronchitis was determined by the presence of self-reported
cough and phlegm production for at least three months a
year for two or more consecutive years. LLN was primarily
defined using the National Health and Nutrition Examination
Survey III (NHANES III) and was alternatively determined
using the Global Lung Initiative (GLI) references.
Covariates
Standard covariates included age, body mass index (BMI),
education, sex, current smoking, and pack-years of smoking.
In addition, mining tenure in the MiDUS Cohort and
self-reported dust and fume exposure in the remaining two
cohorts were included as covariates. These covariates were
chosen because of their biological relevance for the studied
associations. Additional covariates included spirometric patterns and cardiovascular disease, the latter defined by
self-reported physician diagnosis of hypertension, angina,
myocardial infarction, congestive heart failure, or
arrhythmias.
Statistical approach
Summary statistics, including means and standard deviations
or adjusted standard errors of the means, were obtained for
continuous variables, and proportions were obtained for
categorical variables. Non-parametric tests (Wilcoxon
rank-sum) were used for continuous variables, and chi-square
tests and logistic regression were used for categorical variables, using Statistical Analysis Software Package Version
9.3 (SAS, Cary, NC). A two-sided p-value <0.05 was considered statistically significant.
Institutional review board approval
Each study site participating in the COPDGene Study
obtained local institutional review board approval to enroll
participants in this project. The LSC was approved by the
Western Institutional Review Board (20031684, Olympia,
WA). All subjects in the LSC and COPDGene Study provided informed consent to participate in the study. The
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Table 1. Descriptive racial and ethnic differences in demographic and exposure characteristics in the three cohorts.
COPDGene Study
African-American
(n = 3,416)
Characteristic

Mean ± SD or %

LSC

MiDUS Cohort

Hispanic
(n = 378)
NHW (n = 6,884)
62.0 ± 8.9*
52.3%*
169.7 ± 9.5**
82.8 ± 19.5*
28.7 ± 6.0
38.9%*
47.2 ± 26.0*

Mean ± SD or %
53.3 ± 8.9
25.7%
162.5 ± 8.1
75.9 ± 17.0
28.7 ± 6.0
13.0%
33.1 ± 15.4

Hispanic
(n = 2,682)
American Indian
Mean ± SD or %	  (n = 2,467)
52.2 ± 14.3
58.8 ± 11.8
96.6%
93.4%
168.8 ± 7.0
168.6 ± 7.1
82.6 ± 16.4
82.1 ± 15.8
28.9 ± 5.1
28.9 ± 5.1
23.7%
7.5%
10.6 ± 18.5
2.8 ± 11.5

NHW(n = 2,115)
Age (years)
54.6 ± 7.2
53.7 ± 16.0*
Men
55.2%
95.4%*
Height (cm)
171.0 ± 9.7
174.5 ± 7.7*
Weight (kg)
84.9 ± 19.9
87.6 ± 17.0*
BMI (kg/m2)
29.1 ± 6.7
28.7 ± 5.1
Current smoking
80.0%
22.1%*
Pack-years of
38.3 ± 21.6
17.1 ± 24.1*
smoking
≥High school
74.7%
92.2%*
45.5%
75.2%*
42.0%
29.4%
62.3%*
education
Total mining
12.9 ± 11.9
8.8 ± 9.8
13.6 ± 14.0*
tenure (in
years)
Self-reported
61.3%
58.0%*
37.0%
33.5%
exposure to
dust or
fumes
Note: **p < 0.05, *p < 0.01; for the MiDUS Cohort, the p values refer to three-group comparison; non-parametric tests (Wilcoxon rank-sum) were used for continuous variables, and chi-square test was used for categorical variables.
Abbreviations: COPD, chronic obstructive pulmonary disease; LSC, Lovelace Smokers’ Cohort; MiDUS, Mining Dust Exposure in the United States.

MiDUS Cohort was approved (14-058) by the Human
Research Protection Office at the University of New
Mexico (Albuquerque, NM) with a research subject consent waiver.
Data availability
While COPDGene Study data are publicly available through
the database of Genotypes and Phenotypes (dbGaP), data on
the MiDUS Cohort and pooled data from the LSC can be
shared with the appropriate institutional review board and
institutional approvals by contacting the corresponding author.

Results
While AAs in the COPDGene Study and Hispanics in the
remaining two cohorts were younger than the respective
NHWs within each cohort, AIs were older than NHWs in
the MiDUS Cohort (Table 1). The sex ratio was nearly
balanced in the COPDGene Study, but LSC subjects (by
study design) were mainly women, and MiDUS subjects
(belonging to an occupational cohort of miners) were overwhelmingly men. Although minority groups in each cohort
reported lower cumulative pack-years of smoking, AAs in
the COPDGene Study were more likely, and AIs in the
MiDUS Cohort were less likely to report current smoking
than the respective NHWs within each cohort. All minority
groups in each cohort showed a significantly lower educational status than the respective NHWs. In the MiDUS
Cohort, AIs reported lower total mining tenure than the
other groups, and AAs in the COPDGene Study were more
likely to self-report exposure to dust/fumes than the respective NHWs within each cohort.
All minority groups had a lower prevalence of
self-reported physician diagnosis of COPD and

NHW (n = 1,598)
56.2 ± 9.5*
22.6%
166.8 ± 8.6**
78.0 ± 18.9 *
28.0 ± 6.2*
10.1%
40.9 ± 21.4*

spirometric airflow obstruction and higher FEV1/FVC
ratio values than the respective NHWs in each cohort
(Table 2). AAs and AIs had a significantly lower prevalence of chronic bronchitis than the respective NHWs in
each cohort. Further, compared to the respective NHWs,
all minority groups in each cohort showed higher z-scores
for FEV1 (using the NHANES III and GLI reference standards) and FVC (using the NHANES III reference standards). All minority groups reported greater levels of
dyspnea on the mMRC scale than the respective NHWs
in each cohort.
After adjustment for standard covariates, results were
broadly similar to the univariate analysis (Table 3). However,
the associations for self-reported physician diagnosis of
COPD among Hispanics and chronic bronchitis among AI
were no longer significantly different. Furthermore, the
associations for FEV1 z-score among AIs in the MiDUS
Cohort and FVC z-scores among Hispanics in the LSC and
MiDUS Cohort were not significantly different than the
respective NHWs. In addition, the Hispanic association was
no longer significant using the GLI reference standards in
the LSC.
The greater levels of dyspnea (mMRC score) reported by
all minority groups in each cohort were neither explained
by standard covariates (Table 3) nor by differences in spirometric pattern distribution or prevalence of cardiovascular
disease (Table 4).

Discussion
Compared to NHWs, minority groups in three separate
cohorts of smokers or miners demonstrate a lower prevalence of airflow obstruction but greater self-reported dyspnea. AAs have a lower prevalence of chronic bronchitis.
The study findings are unlikely to be explained by differences in age, smoking behavior, socioeconomic status
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Table 2. Univariate analysis of racial and ethnic differences in respiratory outcomes in the three cohorts.
COPDGene Study
Respiratory
outcome

African-American
(n = 3,416)
Mean ± SD or %

LSC

MiDUS Cohort

Hispanic
(n = 378)
NHW (n = 6,884)
55.5%*

Mean ± SD or %
14.8%

Hispanic
(n = 2,682)
American Indian
Mean ± SD or %	  (n = 2,467)
13.3%
15.1%

NHW(n = 2,115)
Airflow
35.7%
26.3%*
obstruction
(GOLD
definition
FEV1/
FVC < 70%)
Airflow
28.9%
43.1%*
16.1%
26.5%*
11.1%
7.1%
18.7%*
obstruction
(FEV1/
FVC < LLN (or
z score
−1.645))
NHANES III
Airflow
27.01%
41.68%*
10.85%
24.23%*
8.3%
6.7%
17.5%*
obstruction
(FEV1/
FVC < LLN (or
z score
−1.645)) GLI
Absolute FVC
3.1 ± 0.9
3.4 ± 1.0*
3.4 ± 0.9
3.5 ± 0.9
4.3 ± 1.0
4.0 ± 0.9
4.6 ± 1.1*
(Ls.)
FVC z score,
−0.73 ± 1.26
−1.10 ± 1.43 *
−0.34 ± 1.17
−0.54 ± 1.21*
−0.10 ± 1.49
0.02 ± 1.42
−0.33 ± 1.33*
NHANES III
FVC z score, GLI
−0.75 ± 1.22
−0.76 ± 1.25
−0.3 ± 1.05
−0.29 ± 1.06
0.05 ± 1.22
−0.16 ± 1.15
0.03 ± 1.27*
2.3 ± 0.9
2.2 ± 1.0*
2.6 ± 0.7
2.5 ± 0.8
3.3 ± 0.9
3.1 ± 0.8
3.4 ± 1.0*
Absolute FEV1
(Ls.)
FEV1 z score,
−1.09 ± 1.44
−1.82 ± 1.82 *
−0.60 ± 1.27
−0.97 ± 1.34*
−0.11 ± 1.41
−0.21 ± 1.30
−0.41 ± 1.57*
NHANES III
FEV1 z score,
−1.13 ± 1.41
−1.57 ± 1.60 *
−0.53 ± 1.18
−0.82 ± 1.23*
−0.10 ± 1.26
−0.25 ± 1.18
−0.37 ± 1.39*
GLI
FEV1/FVC ratio
72.0 ± 13.8
64.3 ± 16.6*
76.6 ± 9.0
72.3 ± 10.6*
77.4 ± 9.7
76.9 ± 8.3
73.2 ± 10.7*
absolute
Ratio z score,
−1.22 ± 2.08
−2.04 ± 2.72 *
−0.59 ± 1.52
−1.02 ± 1.67*
−0.21 ± 1.67
0.14 ± 1.34
−0.64 ± 1.67*
NHANES III
Ratio z score,
−0.90 ± 1.61
−1.57 ± 1.74 *
−0.43 ± 1.1
−0.92 ± 1.22*
−0.22 ± 1.97
−0.16 ± 1.05
−0.71 ± 1.23*
GLI
Self-reported
11.6%
19.0%*
7.7%
13.4%*
7.3%
11.5%
13.7%*
physician
diagnosis of
COPD
Chronic
15.7%
20.6%*
27.2%
24.8%
16.8%
15.7%
18.4*
bronchitisa
mMRC score
1.5 ± 1.5
1.3 ± 1.4*
2.1 ± 1.4
1.7 ± 1.4*
1.3 ± 1.5
2.2 ± 1.6
1.0 ± 1.3*
Score 0
42.3%
45.9%*
19.0%
23.2%
41.9%
26.2%
46.8%
Score 1
11.6%
14.8%*
23.3%
32.1%*
10.6%
7.9%
17.5%
Score 2
13.5%
12.6%
2.4%
2.0%
9.8%
10.5%
10.5%
Score 3
20.2%
17.5%*
42.3%
33.9%*
10.3%
17.0%
8.0%
Score 4
12.4%
9.0%*
13.0%
8.8%
10.8%
29.5%
7.8%
Prevalent
7.6%
12.5%*
26.7%
34.7%*
14.4%
33.2%
17.9%*
self-reported
cardiovascular
disease
Note: **p < 0.05, *p < 0.01; for the MiDUS cohort, the p values refer to three-group comparison; non-parametric tests (Wilcoxon rank-sum) were used for continuous variables, and chi-square test was used for categorical variables.
Abbreviations: COPD, chronic obstructive pulmonary disease; FVC, forced vital capacity; FEV1, Forced expiratory volume in one second; GLI, Global Lung Initiative;
GOLD, Global Obstructive Lung Disease; LSC, Lovelace Smokers’ Cohort; MiDUS, Mining Dust Exposure in the United States; mMRC, Modified Medical Research
Council; NHANES, National Health and Nutrition Examination Survey.
a
Standard definition of chronic bronchitis was defined by cough and phlegm production for at least three months a year for two or more consecutive years.

(measured by proxy variable education), or duration of mining dust exposure since these covariates were adjusted for
in the multivariable analysis.
Although AAs have lower prevalence and death rates from
COPD than Caucasian Americans, several reports have
demonstrated that AAs develop COPD with less intense
cumulative smoking and at a younger age [16–18]. Additional

NHW (n = 1,598)
32.7%*

reports indicate that COPD mortality rates have increased
faster among AAs than Caucasian Americans [3]. Using
quantitative CT scan analysis from the COPDGene substudy,
AAs were shown to have less radiologic emphysema than
NHWs but no significant difference in airway wall thickness
[19]. Among severe COPD patients, AAs are disproportionately represented among those with early-onset disease
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Table 3. Multivariable analysis of racial and ethnic differences in respiratory outcomes in the three cohorts.
Respiratory outcomes
Categorical outcomes
Airflow obstruction (GOLD
definition FEV1/
FVC < 70%)
Airflow obstruction (FEV1/
FVC < LLN (or z score
−1.645)), NHANES III
Airflow obstruction (FEV1/
FVC < LLN (or z score
−1.645)), GLI
Self-reported physician
diagnosis of COPD
Chronic bronchitisa
mMRC score <2
mMRC score ≥ 2

COPDGene Study-African
American

LSC-Hispanic

MiDUS Cohort-Hispanic

MiDUS Cohort-American
Indian

Odds ratio (95% CI)
0.72 (0.65, 0.80)*

Odds ratio (95% CI)
0.45 (0.31, 0.65)*

Odds ratio (95% CI)
0.50 (0.32, 0.78)*

Odds ratio (95% CI)
0.29 (0.18, 0.48)*

0.85 (0.76, 0.94)*

0.64 (0.45, 0.91)*

0.59 (0.50, 0.71)*

0.47 (0.37, 0.59)*

0.80 (0.72,0.89)*

0.44 (0.27, 0.69)*

0.47 (0.39, 0.57)*

0.50 (0.39, 0.62)*

0.56 (0.49, 0.65)*

0.79 (0.48, 1.24)

0.52 (0.26, 1.06)

0.38 (0.19, 0.75)*

0.50 (0.44, 0.56)*
0.61 (0.55, 0.67) *
1.65 (1.49, 1.82)*

0.87 (0.63, 1.18)
0.59(0.45, 0.78)*
1.69 (1.28, 2.23)*

1.42 (0.92, 2.19)
0.68 (0.59, 0.80)*
1.33 (1.15, 1.53)*

1.36 (0.88, 2.12)
0.34 (0.29, 0.40)*
3.33 (2.85, 3.88)*

Continuous outcomes
Difference (95% CI)
Difference (95% CI)
Difference (95% CI)
Difference (95% CI)
FVC z score, NHANES III
0.25 (0.19, 0.32)*
0.15 (0.00, 0.30)**
0.09 (−0.02, 0.19)
−0.19 (−0.30, −0.07)*
FVC z score, GLI
−0.06 (−0.12, −0.01)
−0.04 (−0.18, 0.11)
−0.01 (−0.01, 0.08)
−0.15 (−0.25, −0.05)*
FEV1 z score, NHANES III
0.43 (0.36, 0.51) *
0.26 (0.09, 0.42) *
0.23 (0.12, 0.33)*
0.05 (−0.06, 0.17)
FEV1 z score, GLI
0.18 (0.11, 0.25) *
0.17 (0.01, 0.34)**
0.21 (0.11, 0.30)*
0.02 (−0.08, 0.13)
FEV1/FVC ratio z score,
0.15 ± (0.04, 0.26)*
0.28 (0.08, 0.48)*
0.33 (0.21, 0.45)*
0.44 (0.31, 0.57)*
NHANES III
FEV1/FVC ratio z score, GLI
0.23 (0.16, 0.31) *
0.34 (0.18, 0.50)*
0.41 (0.30, 0.53)*
0.31 (0.19, 0.44)*
mMRC (mean)
0.33 (0.26, 0.39)*
0.27 (0.10, 0.43)*
0.17 (0.06, 0.28)*
0.76 (0.64, 0.88)*
Note: NHWs served as the referent group for separate comparisons in each cohort without pooling data across cohorts. All analyses were adjusted for age,
baseline BMI, and pack-years of smoking as continuous variables, as well as high school education, sex, and current smoking status at baseline as categorical
variables. In addition, total mining tenure was included as a continuous covariate in the MiDUS cohort and exposure to dust and fumes as a categorical
covariate in the other two cohorts. **p < 0.05, *p < 0.01. Categorical mMRC scores were analyzed using logistic regression. For the mean of continuous mMRC
score in the LSC, Hispanics showed a p-value of 0.07.
Abbreviations: COPD, chronic obstructive pulmonary disease; FVC, forced vital capacity; FEV1, forced expiratory volume in one second; GLI, Global Lung Initiative;
GOLD, Global Obstructive Lung Disease; LSC, Lovelace Smokers’ Cohort; MiDUS, Mining Dust Exposure in the United States; NHANES, National Health and
Nutrition Examination Survey.
a
Standard definition of chronic bronchitis was defined by cough and phlegm production for at least three months a year for two or more consecutive years.

Table 4. Multivariable analysis of racial and ethnic differences in mMRC dyspnea score in the three cohorts, with NHWs as the referent group in each cohort,
after additional adjustment for spirometric pattern and self-reported cardiovascular disease.

Categorical outcomes
mMRC < 2
mMRC ≥ 2

COPDGene Study-African
American
Odds ratio (95% CI)
0.50 (0.45, 0.56)*
1.99 (1.78, 2.22)*

LSC-Hispanic
Odds ratio (95% CI)
0.52 (0.39, 0.69)*
1.93 (1.45, 2.58)*

MiDUS Cohort-Hispanic
Odds ratio (95% CI)
0.65 (0.55, 0.76)*
1.36 (1.17, 1.58)*

MiDUS Cohort-American
Indian
Odds ratio (95% CI)
0.36 (0.30, 0.42)*
3.14 (2.68, 3.68)*

Continuous outcomes
Difference (95% CI)
Difference (95% CI)
Difference (95% CI)
Difference (95% CI)
mMRC (mean)
0.40 (0.34, 0.46)*
0.33 (0.17, 0.49)*
0.21 (0.10, 0.32)*
0.71 (0.59, 0.83)*
Note: The analyses were adjusted for age, baseline BMI, total mining tenure, and pack-years of smoking as continuous variables, as well as high school education, sex, current smoking status, spirometric patterns (restrictive or obstructive), and cardiovascular disease at baseline as categorical variables. In addition,
total mining tenure was included as a continuous covariate in the MiDUS cohort and exposure to dust and fumes as a categorical covariate in the other two
cohorts. **p < 0.05, *p < 0.01.
Abbreviations: COPD, chronic obstructive pulmonary disease; LSC, Lovelace Smokers’ Cohort; MiDUS, Mining Dust Exposure in the United States; mMRC, Modified
Medical Research Council.

(occurring before 55 years) than those with late-onset disease
[20]. It has been previously reported that AAs have worse
dyspnea and health-related quality of life than Caucasians
after adjustment for lung function. One possible explanation
may be their use of fewer respiratory medications, lower
utilization of medical care, and poorer access to care [21,
22]. Another possible explanation is that AAs are twice as
likely as NHWs to report a history of asthma [23]. COPD
patients with concomitant asthma experience poorer quality
of life and greater dyspnea than those without asthma. The
presence of comorbidities such as gastroesophageal reflux
has a greater negative impact on dyspnea in AAs than

NHWs, which may also help explain their greater report of
dyspnea [24].
In a study utilizing the NHANES III data, an obstructive
pattern was less common in Mexican Americans (8.2%) than
NHWs (15.1%) or AAs (12.4%) [25]. Several studies have
demonstrated reduced prevalence and mortality of COPD,
higher baseline lung function, and a slower decline in lung
function in Hispanic groups, than NHWs [5, 6, 26–29].
These findings may contribute to the “Hispanic paradox”
referring to the fact that despite their lower socioeconomic
and higher comorbidity indices, Hispanics have a lower
all-cause mortality rate than NHWs [30]. The present study
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indicates that the Hispanic “protective effect” for airflow
obstruction that our group first described in urban New
Mexico women smokers [5, 6] is also true for rural male
New Mexico miners. While some investigators have attributed
the Hispanic “protective” effect to their lower cumulative
exposure to tobacco smoke [26], others demonstrate a protective effect of the AI ancestry component in racially
admixed Hispanic populations of New Mexico and Costa
Rica [5, 31]. Studies have also identified unique genetic loci
that may play a role in COPD pathogenesis in Hispanic
populations [32]. Additionally, the greater dyspnea score in
Hispanics than NHWs is consistent with their lower
health-related quality of life previously reported in the LSC
[33] and is not explained by differences in either lung function or CT measure of lung structure [34]. It is possible
that, like in AAs, the disparities in access to healthcare,
health literacy, and health behavior may explain this difference in Hispanics [33].
Studies on AIs and COPD are limited, and none have
looked at participation in dusty trades to the best of our
knowledge. Consistent with our findings, county-level mortality rates from COPD in AI communities of New Mexico
are generally low [35]. One study on First Nations people
from Saskatchewan, Canada, of mean age of 34.8 ± 14.5 years,
describes a 7–9% prevalence of chronic bronchitis [36],
significantly lower than the prevalence rates in the present
study. Other studies similarly report low prevalence rates
for chronic bronchitis [37, 38]. Our study results suggest
that the relatively lower level of chronic bronchitis in AIs
in the univariate analysis is likely explained by covariates.
The effect of different diagnostic criteria on COPD
prevalence has been previously described. For example,
using the LLN criteria in older subjects is associated with
a lower prevalence of COPD than the GOLD guidelines
[39]. While the most used reference equations in the
United States remain those reported by Hankinson et al.
in 1999, based on the third National Health and Nutrition
Examination Survey, there has been a movement worldwide
toward adopting the GLI 2012 reference equations [40].
The use of LLN using the GLI equations may be related
to a lower prevalence of airflow obstruction in our study
than the NHANES III standards. As previously published,
the differences in the diagnosis and severity categorization
of obstructive lung disease in individual subjects, particularly older, taller/shorter subjects, can be significant and
may result in differences in clinical management [41].
Therefore, while one prediction equation cannot be
endorsed over the other, generally, they should not be used
interchangeably.
The present study has several strengths, including analyzing three minority groups in three separate cohorts
without pooling data across cohorts. We have reproduced
the findings described in Hispanic smokers in previous
studies [5, 6, 26–29] in an occupational cohort of miners,
a group at risk for COPD but inadequately studied. Our
inclusion of AIs covers a critical gap in this field of
research. It helps support our innovative hypothesis that
the AI ancestry component in racially admixed Hispanics

of the Southwestern United States may explain their “protection” from airflow obstruction [5]. Although the present
study used rigorous spirometric criteria, potential limitations are noted. First, an obstructive spirometric pattern
may not confirm the presence of COPD since it may also
be seen in asthma, particularly given that the spirometry
was not specifically obtained after bronchodilator administration. Further, the study does not address other
COPD-related outcomes, which include hospitalizations,
respiratory exacerbations, progression of dyspnea, onset of
respiratory failure, and mortality. Self-reported race and
ethnicity may not be accurate, potentially leading to misclassification in the use of spirometric reference equations.
However, in our previous study, self-reported ethnicity was
highly correlated with genetic ancestry information markers
[5]. No well-validated spirometric reference equations currently exist for AIs. Although differences in genetic predisposition might underlie our findings, the present study
may have been limited by differences in cultural, geographic, dietary, psychosocial stress, and socioeconomic
factors between and within the three racial and ethnic
categories [42–44]. In addition, smoking behavior is a complex variable that may not be entirely captured by measures
such as pack-years of exposure and current smoking status.
It is difficult to account for factors such as type of cigarettes, depth of inhalation, or number of puffs per cigarette,
which may differ between minority and non-minority populations [5]. However, previous reports provide evidence
that Hispanics may underreport the amount of cigarette
smoking, which, if underestimated in our study, would
only strengthen the observed protective nature of Hispanic
ethnicity for airflow obstruction [45]. The study analyzed
only baseline data of three longitudinal cohorts.
Longitudinal analyses in the future could provide further
information to better evaluate/interpret the obtained
cross-sectional results. Finally, findings may not be representative of racial/ethnic minorities in all parts of the
United States because participants in the COPDGene Study
were recruited from select clinical centers across the United
States, and the LSC and the MiDUS Cohort were recruited
from communities in New Mexico.

Conclusions
Our finding of a lower prevalence of airflow obstruction
but greater self-reported dyspnea in all minority groups
relative to NHWs suggests that there is insufficient mechanistic research into racial and ethnic disparities in COPD
to disentangle biological, social, and environmental effects
on airway diseases. Genomic, proteomic, metabolomic,
and behavioral studies in the future may help better
understand the pathophysiology of racial and ethnic differences. This, in turn, may result in new therapeutic
strategies and drug targets. As COPD patients of the future
will progressively include more racial and ethnic minorities, targeted preventive strategies and new therapeutics
are needed among smokers and workers engaged in
dusty trades.
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